Literature DB >> 20133151

Hemovigilance in developing countries.

Yasmin Ayob1.   

Abstract

Hemovigilance like quality systems and audits has become an integral part of the Blood Transfusion Service (BTS) in the developed world and has contributed greatly to the development of the blood service. However developing countries are still grappling with donor recruitment and efforts towards sufficiency and safety of the blood supply. In these countries the BTS is generally fragmented and a national hemovigilance program would be difficult to implement. However a few developing countries have an effective and sustainable blood program that can deliver equitable, safe and sufficient blood supply to the nation. Different models of hemovigilance program have been introduced with variable success. There are deficiencies but the data collected provided important information that can be presented to the health authorities for effective interventions. Hemovigilance program modeled from developed countries require expertise and resources that are not available in many developing countries. Whatever resources that are available should be utilized to correct deficiencies that are already apparent and obvious. Besides there are other tools that can be used to monitor the blood program in the developing countries depending on the need and the resources available. More importantly the data collected should be accurate and are used and taken into consideration in formulating guidelines, standards and policies and to affect appropriate interventions. Any surveillance program should be introduced in a stepwise manner as the blood transfusion service develops. Copyright 2009 The International Association for Biologicals. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20133151     DOI: 10.1016/j.biologicals.2009.10.002

Source DB:  PubMed          Journal:  Biologicals        ISSN: 1045-1056            Impact factor:   1.856


  6 in total

1.  Estimation of the prevalence and rate of acute transfusion reactions occurring in Windhoek, Namibia.

Authors:  Benjamin P L Meza; Britta Lohrke; Robert Wilkinson; John P Pitman; Ray W Shiraishi; Naomi Bock; David W Lowrance; Matthew J Kuehnert; Mary Mataranyika; Sridhar V Basavaraju
Journal:  Blood Transfus       Date:  2013-11-15       Impact factor: 3.443

2.  Evaluation of the WHO global database on blood safety.

Authors:  Udhayashankar Kanagasabai; Dejana Selenic; Michelle S Chevalier; Bakary Drammeh; Michael Qualls; Ray W Shiraishi; Naomi Bock; Irene Benech; Fatima D Mili
Journal:  Vox Sang       Date:  2020-09-30       Impact factor: 2.996

3.  Role of National Accreditation Board of Hospitals and Healthcare Providers (NABH) core indicators monitoring in quality and safety of blood transfusion.

Authors:  Anshu Gupta; Chhavi Gupta
Journal:  Asian J Transfus Sci       Date:  2016 Jan-Jun

4.  Baseline assessment findings of the Africa Society for Blood Transfusion Step-Wise Accreditation Programme in 10 sub-Saharan African countries, 2016-2018.

Authors:  Udhayashankar Kanagasabai; Michael Qualls; Ray W Shiraishi; Laura Eno; Innocent Zungu; Lesley Bust; Bakary Drammeh; Dejana Selenic
Journal:  Vox Sang       Date:  2022-03-10       Impact factor: 2.996

5.  Alternative blood products and clinical needs in transfusion medicine.

Authors:  Carolyn Whitsett; Stefania Vaglio; Giuliano Grazzini
Journal:  Stem Cells Int       Date:  2012-04-08       Impact factor: 5.443

6.  The use of transfusion quality indicators as a tool for hemovigilance system implementation at a tertiary care center in Saudi Arabia.

Authors:  Salwa I Hindawi; Maha A Badawi; Edwin T Raj; Kholoud A Gholam; Seraj O Al-Weail; Fatima Azher
Journal:  Saudi Med J       Date:  2016-05       Impact factor: 1.484

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.